Cite
HARVARD Citation
Kalams, S. et al. (n.d.). Neither vaginal nor buccal administration of 800 μg misoprostol alters mucosal and systemic immune activation or the cervicovaginal microbiome: a pilot study. European journal of contraception & reproductive health care. pp. 436-442. [Online].